Patents by Inventor D. Robert Sutherland

D. Robert Sutherland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD109 nucleic acid molecules, polypeptides and methods of use
    Patent number: 7700316
    Abstract: The invention is a CD109 nucleic acid molecule and its corresponding polypeptide. The invention also includes biologically functional equivalent nucleic acid molecules and polypeptides. The invention also relates to methods of using these nucleic acid sequences and polypeptides in medical diagnosis and treatment and in drug screening.
    Type: Grant
    Filed: March 7, 2002
    Date of Patent: April 20, 2010
    Inventors: Andre Schuh, D. Robert Sutherland
  • Method of purifying a population of cells enriched for hematopoietic stem cells populations of cells obtained thereby and methods of use thereof
    Patent number: 5665557
    Abstract: The invention relates to methods of obtaining compositions enriched in hematopoietic stem cells by separating out an enriched fraction of cells expressing the marker CDw109. Methods of obtaining compositions enriched in hematopoietic megakaryocyte progenitor cells are also provided. Compositions enriched for stem cells and populations of cells obtained therefrom are also provided by the invention. Methods of use of the cells are also included.
    Type: Grant
    Filed: November 14, 1994
    Date of Patent: September 9, 1997
    Assignees: Systemix, Inc., The Toronto Hospital Research Institute
    Inventors: Lesley Murray, D. Robert Sutherland